The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

Allergy. 2023 Mar;78(3):855-858. doi: 10.1111/all.15624. Epub 2022 Dec 30.

Gemma E Hartley¹, Emily S J Edwards¹, Nirupama Varese¹, Irene Boo², Pei M Aui¹, Scott J Bornheimer³, P Mark Hogarth^{1

4

5}, Heidi E Drummer^{2

6

7}, Robyn E O'Hehir^{1

8}, Menno C van Zelm^{1

8}

¹ Allergy and Clinical Immunology Laboratory, Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
² Viral Entry and Vaccines Group, Burnet Institute, Melbourne, Victoria, Australia.
³ BD Biosciences, San Jose, California, USA.
⁴ Immune Therapies Group, Burnet Institute, Melbourne, Victoria, Australia.
⁵ Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.
⁶ Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
⁷ Department of Microbiology, Monash University, Clayton, Victoria, Australia.
⁸ Allergy, Asthma and Clinical Immunology Service, Alfred Hospital, Melbourne, Victoria, Australia.

No abstract available

Publication types